Results 41 to 50 of about 31,178 (269)

Measles virus causes immunogenic cell death in human melanoma [PDF]

open access: yes, 2011
Oncolytic viruses (OV) are promising treatments for cancer, with several currently undergoing testing in randomised clinical trials. Measles virus (MV) has not yet been tested in models of human melanoma.
Bond, Jacquelyn   +14 more
core   +1 more source

Oncolytic Virotherapy: From Bench to Bedside

open access: yesFrontiers in Cell and Developmental Biology, 2021
Oncolytic viruses are naturally occurring or genetically engineered viruses that can replicate preferentially in tumor cells and inhibit tumor growth. These viruses have been considered an effective anticancer strategy in recent years.
Ludi Yang   +9 more
doaj   +1 more source

Oncolytic viruses and pancreatic cancer

open access: yesCancer Treatment and Research Communications, 2022
Today, the pancreatic cancer prognosis is poor and genetic technology is developing to treat various types of cancers. Scientists are actively looking for a new technique to design a therapeutic strategy to treat pancreatic cancer. Several oncolytic viruses are known to be valuable tools for pancreatic cancer treatment. Recent Studies demonstrate their
Vahideh Hamidi-Sofiani   +5 more
openaire   +3 more sources

Multiscale model for the effects of adaptive immunity suppression on the viral therapy of cancer

open access: yes, 2013
Oncolytic virotherapy - the use of viruses that specifically kill tumor cells - is an innovative and highly promising route for treating cancer. However, its therapeutic outcomes are mainly impaired by the host immune response to the viral infection.
Ferreira, Silvio C   +3 more
core   +2 more sources

Oncolytic viruses and cancer treatment

open access: yesKlinicka onkologie, 2023
The fundamental difference between tumor and normal tissue growth is the emergence of the microenvironment with diminished or extinguished immunogenicity. One of the main functions of oncolytic viruses is the formation of such a microenvironment, which leads to a revival of immunological processes and loss of viability of cancer cells.
H, Španielová, R, Brdička
openaire   +2 more sources

Oncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients

open access: yesJournal of Translational Medicine, 2012
Oncolytic viruses refer to those that are able to eliminate malignancies by direct targeting and lysis of cancer cells, leaving non-cancerous tissues unharmed.
Patil Sandeep S   +4 more
doaj   +1 more source

Mathematical modeling of tumor therapy with oncolytic viruses: Effects of parametric heterogeneity on cell dynamics [PDF]

open access: yes, 2006
One of the mechanisms that ensure cancer robustness is tumor heterogeneity, and its effects on tumor cells dynamics have to be taken into account when studying cancer progression.
Karev, Georgy P.   +2 more
core   +4 more sources

Oncolytic viruses: overcoming translational challenges [PDF]

open access: yesJournal of Clinical Investigation, 2019
Oncolytic virotherapy (OVT) is a promising approach in which WT or engineered viruses selectively replicate and destroy tumor cells while sparing normal ones. In the last two decades, different oncolytic viruses (OVs) have been modified and tested in a number of preclinical studies, some of which have led to clinical trials in cancer patients.
Jordi Martinez-Quintanilla   +3 more
openaire   +2 more sources

Evolving role of seneca valley virus and its biomarker TEM8/ANTXR1 in cancer therapeutics

open access: yesFrontiers in Molecular Biosciences, 2022
Oncolytic viruses have made a significant inroad in cancer drug development. Numerous clinical trials are currently investigating oncolytic viruses both as single agents or in combination with various immunomodulators.
Virginia Corbett   +3 more
doaj   +1 more source

A dsRNA Viral Transcriptional Regulator Evades Innate Immunity by Hijacking Host CoTranscription Factor DHX9

open access: yesAdvanced Science, EarlyView.
This study identifies a new viral mechanism by a viral protein σ3 that functions as a vTR to suppress NF‐κB gene expression via its direct interaction with the host helicase DHX9. Through their interaction, σ3 not only impairs the initial recruitment of Pol II but also affects Pol II pause‐release and ultimately suppresses NF‐κB gene expression ...
Xueyang Pang   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy